8-K Q4 2019 EARNINGS RELEASE

Company

ENANTA PHARMACEUTICALS INC

Filed

November 21, 2019

Period of Report

November 21, 2019

Accession Number

0001564590-19-044095

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →